Avenique Ltd Trading Suspension Lifted

Effective Date: November 5, 2026. Trading Group: XT Group.

Reader Takeaway: Investors regain liquidity via the exchange; the XT classification demands caution due to specific regulatory surveillance.

What just happened

The BSE has officially revoked the suspension of trading in the equity shares of Avenique Ltd. This action allows the company to resume normal market operations after previously being barred from the exchange platform due to non-compliance issues.

Why this matters

The resumption of trading provides long-awaited liquidity for existing shareholders who were unable to exit or adjust their positions during the suspension period. The company has now fulfilled the mandatory requirement of payment of annual listing fees, aligning itself with the SEBI Master Circular dated January 30, 2026.

What changes now

Starting November 5, 2026, the company’s scrip (530701) will be available for trading. Investors should note that the stock will be placed in the "XT" group. Additionally, the scrip will undergo a Special Pre-open Session (SPOS) to facilitate orderly price discovery upon its return to the trading window.

Risks to watch

Trading in the XT group often implies higher scrutiny and volatility compared to mainstream trading groups. Investors should carefully review exchange notice 20120216-29 to understand the specific rules governing the Special Pre-open Session and the limitations that may apply to trading these shares.

What to track next

Market participants should monitor the initial price discovery phase during the SPOS on the resumption date. This will provide an indicator of fair value after the prolonged period of inactivity.